论文信息 - Metastatic breast cancer. Length and quality of life. - 字舞流文

Metastatic breast cancer. Length and quality of life.

WITHIN the young discipline of medical oncology, the systemic therapy of metastatic breast cancer has a long history. Bilateral oophorectomy, which was noted in the 19th century to cause the regres...

L. Norton | L Norton

[1] Peters Wp. High-dose chemotherapy and autologous bone marrow support for breast cancer. , 1991, Important advances in oncology.

[2] Henderson Ic. Window of opportunity. , 1991 .

[3] T. Dexter,et al. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[4] C. Spurr,et al. Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. , 1991, The New England journal of medicine.

[5] A. Eastman,et al. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. , 1990, Biochemical pharmacology.

[6] M. Tattersall,et al. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. , 1987, The New England journal of medicine.